Ingrid Bahner

Ingrid Bahner

Auto-generated profile, based on publicly available information

Ingrid Bahner

Morsani College of Medicine, University of South Florida, Scholarly Concentrations Program, Tampa, USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2023 in Academic Medicine
Verified
Journal Article
Open access
RWRachel K. Wolfson
Rachel K. Wolfson
PFPaige C. Fairchild
Paige C. Fairchild
IBIngrid Bahner
Ingrid Bahner
DBDwayne M. Baxa
Dwayne M. Baxa
DBDeborah R. Mba Birnbaum
Deborah R. Mba Birnbaum
SSStephen M Sozio
Stephen M Sozio
Purpose: With the United States Medical Licensing Examination Step 1 transition to pass/fail in 2022, uncertainty exists regarding how other residency application components, including research conducted during medical school, will inform interview and ranking decisions. The authors explore program director (PD) views on medical student research, the importance of disseminating that work, and the translatable skill set of research participation. Method: Surveys were distributed to all U.S. residency PDs and remained open from August to November 2021 to query the importance of research participation in assessing applicants, whether certain types of research were more valued, productivity measures that reflect meaningful research participation, and traits for which research serves as a proxy. The survey also queried whether research would be more important without a numeric Step 1 score and the importance of research vs other application components. Results: A total of 885 responses from 393 institutions were received. Ten PDs indicated that research is not considered when reviewing applicants, leaving 875 responses for analysis. Among 873 PDs (2 nonrespondents), 358 (41.0%) replied that meaningful research participation will be more important in offering interviews. A total of 164 of 304 most competitive specialties (53.9%) reported increased research importance compared with 99 of 282 competitive (35.1%) and 95 of 287 least competitive (33.1%) specialties. PDs reported that meaningful research participation demonstrated intellectual curiosity (545 [62.3%]), critical and analytical thinking skills (482 [55.1%]), and self-directed learning skills (455 [52.0%]). PDs from the most competitive specialties were significantly more likely to indicate that they value basic science research vs PDs from the least competitive specialties. Conclusions: This study demonstrates how PDs value research in their review of applicants, what they perceive research represents in an applicant, and how these views are shifting as the Step 1 exam transitions to pass/fail.

1 January 1996 in Antisense and Nucleic Acid Drug Development
Verified
Journal Article
Closed access
CZChangyoung Zhou
Changyoung Zhou
IBI. Bahner
I. Bahner
JRJohn J. Rossi
John J. Rossi
DKDonald Kohn
Donald Kohn
We have analyzed expression of anti-HIV-1 hammerhead ribozymes in the context of retroviral vectors. To determine optimal vector designs for ribozyme expression, we compared three vectors, each of which contained the same pair of anti-HIV-1 hammerhead ribozymes in tandem. Despite the presence of vastly different amounts of vector-derived flanking sequences, the ribozymes produced by each vector had similar cleavage activity when assayed in vitro. The ribozyme vectors were packaged into amphotropic virion and used to transduce human CEM T lymphocytes. Analysis by Northern blot and RNAse protection assays demonstrated that the highest steady-state levels of ribozyme-containing transcripts were produced by a vector in which the ribozymes were expressed under transcriptional control of the vector MoMuLV LTR. Despite these differences in the levels of ribozyme transcripts achieved by the vectors, their ability to confer resistance to HIV-1 replication was similar. Therefore, other factors than the absolute levels of ribozymes play a role in determining the effectiveness of ribozyme vectors to inhibit HIV-1. These may include structural features of the transcripts that affect the antisense effects of the ribozyme constructs, the actual catalytic activity of the ribozymes, their RNA folding, the binding of proteins, and the intracellular localization. Greater understanding of these factors may permit more effective application of ribozymes to inhibit gene expression.

26 August 2011 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
SHSheng-He Huang
Sheng-He Huang
CWChu-Hua Wu
Chu-Hua Wu
Shibo JiangShibo Jiang
Shibo Jiang
IBIngrid Bahner
Ingrid Bahner
ALAlbert S. Lossinsky
Albert S. Lossinsky
AJAmbrose Y. Jong
Ambrose Y. Jong
Cryptococcus neoformans causes life-threatening meningoencephalitis, particularly prevalent in AIDS patients. The interrelationship between C. neoformans and HIV-1 is intriguing, as both pathogens elicit severe neuropathological complications. We have previously demonstrated that the HIV-1 gp41 ectodomain fragments gp41-I33 (amino acids 579-611) and gp41-I90 (amino acids 550-639) can enhance C. neoformans binding to HBMECs (human brain microvascular endothelial cells). Both peptides contain the loop region of gp41. In the present study, we used immunofluorescence microscopy and transmission and scanning electron microscopy to explore the underlying mechanisms. Our findings indicated that both C. neoformans and gp41-I90 up-regulated ICAM-1 (intercellular adhesion molecule 1) on the HBMECs and elicited membrane ruffling on the surface of HBMECs. The HIV-1 gp41 ectodomain could also induce CD44 and β-actin redistribution to the membrane lipid rafts, but it could not enhance PKCα (protein kinase Cα) phosphorylation like C. neoformans. Instead, gp41-I90 was able to induce syncytium formation on HBMECs. The results of the present study suggest HIV-1 gp41-enhanced C. neoformans binding to HBMECs via gp41 core domain-induced membrane activities, revealing a potential mechanism of invasion for this pathogenic fungus into the brain tissues of HIV-1-infected patients.

1 October 2012 in Medical Science Educator
Verified
Journal Article
Closed access
PDF file
IBIngrid Bahner
Ingrid Bahner
CSCharurut Somboonwit
Charurut Somboonwit
SPSusan Pross
Susan Pross
RCRoberta J. Collins
Roberta J. Collins
SSSamuel Saporta
Samuel Saporta

10 February 2022 in Medical Science Educator
Verified
Journal Article
Open access
PDF file
ABAndrea N. Belovich
Andrea N. Belovich
IBIngrid Bahner
Ingrid Bahner
GBGiulia Bonaminio
Giulia Bonaminio
ABAnthony Brenneman
Anthony Brenneman
WBWilliam S. Brooks
William S. Brooks
RVRichard C. Vari
Richard C. Vari
The virtual age of learning is no longer a concern of the future. It is here. The Fall 2021 Webinar Audio Series (WAS) of the International Association of Medical Science Educators (IAMSE), titled “Back to the Future: Maximizing Student Learning and Wellbeing in the Virtual Age,” was designed to help health science educators equip themselves with tools to teach the next generation of health care professionals successfully. From September 2, 2021 to September 30, 2021, the Fall 2021 Series was broadcast live to audiences at academic institutions worldwide in five weekly webinars. This five-part webinar series explored theories and best practices in delivering content over virtual and online media while simultaneously promoting a positive learning environment and enhanced student wellbeing.

16 October 2015 in Medical Science Educator
Verified
Journal Article
Closed access
PDF file
IBIngrid Bahner
Ingrid Bahner
FSFrazier Stevenson
Frazier Stevenson
KZKira Zwygart
Kira Zwygart